annual operating expenses:
$592.14M+$40.57M(+7.36%)Summary
- As of today (July 27, 2025), NTLA annual total operating expenses is $592.14 million, with the most recent change of +$40.57 million (+7.36%) on December 31, 2024.
- During the last 3 years, NTLA annual operating expenses has risen by +$291.24 million (+96.79%).
- NTLA annual operating expenses is now at all-time high.
Performance
NTLA Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$137.43M-$11.89M(-7.96%)Summary
- As of today (July 27, 2025), NTLA quarterly total operating expenses is $137.43 million, with the most recent change of -$11.89 million (-7.96%) on March 31, 2025.
- Over the past year, NTLA quarterly operating expenses has dropped by -$5.50 million (-3.85%).
- NTLA quarterly operating expenses is now -11.62% below its all-time high of $155.50 million, reached on March 31, 2022.
Performance
NTLA quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
NTLA Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.4% | -3.9% |
| 3 y3 years | +96.8% | -11.6% |
| 5 y5 years | +296.2% | +199.0% |
NTLA Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +96.8% | -10.7% | +22.4% |
| 5 y | 5-year | at high | +296.2% | -11.6% | +180.5% |
| alltime | all time | at high | +2943.9% | -11.6% | +5439.5% |
NTLA Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $137.43M(-8.0%) |
| Dec 2024 | $592.14M(+7.4%) | $149.32M(-3.0%) |
| Sep 2024 | - | $153.88M(+5.4%) |
| Jun 2024 | - | $146.00M(+2.1%) |
| Mar 2024 | - | $142.94M(+3.6%) |
| Dec 2023 | $551.57M(+8.1%) | $137.97M(-3.6%) |
| Sep 2023 | - | $143.10M(-1.9%) |
| Jun 2023 | - | $145.93M(+17.2%) |
| Mar 2023 | - | $124.56M(+0.7%) |
| Dec 2022 | $510.29M(+69.6%) | $123.66M(+4.1%) |
| Sep 2022 | - | $118.80M(+5.8%) |
| Jun 2022 | - | $112.33M(-27.8%) |
| Mar 2022 | - | $155.50M(+66.7%) |
| Dec 2021 | $300.90M(+54.6%) | $93.27M(+17.8%) |
| Sep 2021 | - | $79.20M(+4.8%) |
| Jun 2021 | - | $75.57M(+42.9%) |
| Mar 2021 | - | $52.87M(+7.9%) |
| Dec 2020 | $194.58M | $48.99M(-2.6%) |
| Sep 2020 | - | $50.32M(+2.1%) |
| Jun 2020 | - | $49.30M(+7.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $45.96M(+12.9%) |
| Dec 2019 | $149.47M(+23.2%) | $40.71M(+13.3%) |
| Sep 2019 | - | $35.94M(-6.8%) |
| Jun 2019 | - | $38.58M(+12.7%) |
| Mar 2019 | - | $34.24M(+19.6%) |
| Dec 2018 | $121.30M(+26.8%) | $28.63M(-9.1%) |
| Sep 2018 | - | $31.51M(+0.8%) |
| Jun 2018 | - | $31.27M(+4.6%) |
| Mar 2018 | - | $29.90M(-4.7%) |
| Dec 2017 | $95.67M(+96.7%) | $31.38M(+35.3%) |
| Sep 2017 | - | $23.19M(+5.7%) |
| Jun 2017 | - | $21.93M(+14.5%) |
| Mar 2017 | - | $19.16M(+16.5%) |
| Dec 2016 | $48.64M(+150.0%) | $16.45M(+30.9%) |
| Sep 2016 | - | $12.57M(+12.7%) |
| Jun 2016 | - | $11.15M(+31.6%) |
| Mar 2016 | - | $8.47M(+17.9%) |
| Dec 2015 | $19.45M | $7.18M(+44.0%) |
| Sep 2015 | - | $4.99M(+4.0%) |
| Jun 2015 | - | $4.80M(+93.4%) |
| Mar 2015 | - | $2.48M |
FAQ
- What is Intellia Therapeutics, Inc. annual total operating expenses?
- What is the all time high annual operating expenses for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. annual operating expenses year-on-year change?
- What is Intellia Therapeutics, Inc. quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. quarterly operating expenses year-on-year change?
What is Intellia Therapeutics, Inc. annual total operating expenses?
The current annual operating expenses of NTLA is $592.14M
What is the all time high annual operating expenses for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high annual total operating expenses is $592.14M
What is Intellia Therapeutics, Inc. annual operating expenses year-on-year change?
Over the past year, NTLA annual total operating expenses has changed by +$40.57M (+7.36%)
What is Intellia Therapeutics, Inc. quarterly total operating expenses?
The current quarterly operating expenses of NTLA is $137.43M
What is the all time high quarterly operating expenses for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high quarterly total operating expenses is $155.50M
What is Intellia Therapeutics, Inc. quarterly operating expenses year-on-year change?
Over the past year, NTLA quarterly total operating expenses has changed by -$5.50M (-3.85%)